» Articles » PMID: 19620957

An in Vitro FluoroBlok Tumor Invasion Assay

Overview
Journal J Vis Exp
Date 2009 Jul 22
PMID 19620957
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The hallmark of metastatic cells is their ability to invade through the basement membrane and migrate to other parts of the body. Cells must be able to both secrete proteases that break down the basement membrane as well as migrate in order to be invasive. BD BioCoat Tumor Invasion System provides cells with conditions that allow assessment of their invasive property in vitro(1,2). It consists of a BD Falcon FluoroBlok 24-Multiwell Insert Plate with an 8.0 micron pore size PET membrane that has been uniformly coated with BD Matrigel Matrix. This uniform layer of BD Matrigel Matrix serves as a reconstituted basement membrane in vitro providing a true barrier to non-invasive cells while presenting an appropriate protein structure to study invasion. The coating process occludes the pores of the membrane, blocking non-invasive cells from migrating through the membrane. In contrast, invasive cells are able to detach themselves from and migrate through the coated membrane. Quantitation of cell invasion can be achieved by either pre- or post-cell invasion labeling with a fluorescent dye such as DiIC(12;)(3) or calcein AM, respectively, and measuring the fluorescence of invading cells. Since the BD FluoroBlok membrane effectively blocks the passage of light from 490-700 nm at >99% efficiency, fluorescently-labeled cells that have not invaded are not detected by a bottom-reading fluorescence plate reader. However, cells that have invaded to the underside of the membrane are no longer shielded from the light source and are detected with the respective plate reader. This video demonstrates an endpoint cell invasion assay, using calcein AM to detect invaded cells.

Citing Articles

Modifications to the Transwell Migration/Invasion Assay Method That Eases Assay Performance and Improves the Accuracy.

Stoellinger H, Alexanian A Assay Drug Dev Technol. 2022; 20(2):75-82.

PMID: 35196113 PMC: 8968842. DOI: 10.1089/adt.2021.140.


Ozone Exposure During Implantation Increases Serum Bioactivity in HTR-8/SVneo Trophoblasts.

Miller C, Stewart E, J Snow S, Williams W, Richards J, Thompson L Toxicol Sci. 2019; 168(2):535-550.

PMID: 30649513 PMC: 6582634. DOI: 10.1093/toxsci/kfz003.


The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity.

Zahreddine H, Culjkovic-Kraljacic B, Emond A, Pettersson F, Midura R, Lauer M Elife. 2017; 6.

PMID: 29111978 PMC: 5705209. DOI: 10.7554/eLife.29830.


MLK3 phosphorylation by ERK1/2 is required for oxidative stress-induced invasion of colorectal cancer cells.

Schroyer A, Stimes N, Abi Saab W, Chadee D Oncogene. 2017; 37(8):1031-1040.

PMID: 29084209 PMC: 5823719. DOI: 10.1038/onc.2017.396.


UCH-L1 promotes invasion of breast cancer cells through activating Akt signaling pathway.

Luo Y, He J, Yang C, Orange M, Ren X, Blair N J Cell Biochem. 2017; 119(1):691-700.

PMID: 28636190 PMC: 5705264. DOI: 10.1002/jcb.26232.


References
1.
Takada Y, Kobayashi Y, Aggarwal B . Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem. 2005; 280(17):17203-12. DOI: 10.1074/jbc.M500077200. View

2.
Nair A, Shishodia S, Ahn K, Kunnumakkara A, Sethi G, Aggarwal B . Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion. J Immunol. 2006; 177(8):5612-22. DOI: 10.4049/jimmunol.177.8.5612. View

3.
Sethi G, Ahn K, Pandey M, Aggarwal B . Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood. 2006; 109(7):2727-35. DOI: 10.1182/blood-2006-10-050807. View

4.
Harikumar K, Kunnumakkara A, Ahn K, Anand P, Krishnan S, Guha S . Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood. 2008; 113(9):2003-13. PMC: 2947354. DOI: 10.1182/blood-2008-04-151944. View